Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Original study is classified as reliable without restriction (Klimisch 1) because it was conducted according to GLP and followed guidelines (OECD 401, U.S. EPA/TSCA) that were acceptable at the time the study was performed. It is rated K2 (with restrictions) as it is on a surrogate substance.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
Hexadec-1-ene
EC Number:
211-105-8
EC Name:
Hexadec-1-ene
Cas Number:
629-73-2
IUPAC Name:
hexadec-1-ene
Details on test material:
- Name of test material (as cited in study report): Gulftene 16
- Test substance: C16 alpha olefin
- Physical state: Liquid, colourless, low viscosity
- Composition of test material, percentage of components:
100% Gulftene 16
(93.0% 1-hexadecene, 2% 2-Ethyl-1-Tetradecene, 2% 2-Butyl-1-Dodecene, 2% 2-Hexyl-1-Decene, and 1% Hexadecene-N)
- Storage condition of test material: Stored in room temperature in a chemical storage cabinet
- Molecular formula (if other than submission substance): C16H32
- Molecular weight (if other than submission substance): 224.45
- Smiles notation (if other than submission substance): CCCCCCCCCCCCCCC=C
- InChl (if other than submission substance): InChI=1S/C16H32/c1-3-5-7-9-11-13-15-16-14-12-10-8-6-4-2/h3H,1,4-16H2,2H3

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Sprague-Dawley, Incorporated
- Age at study initiation: 7 to 13 weeks
- Weight at study initiation: 200 to 299 grams
- Other: albino
- Fasting period before study: 18 hours
- Housing: Separated by sex, 5 per cage, housed in wire floor cages
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 68 to 74
- Humidity (%): 45 to 56
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: 10 g/kg
Doses:
5 g/kg and 10 g/kg; individual doses were adjusted according to rat body weight.
10 g/kg: (Dose did not exceed more than 1.0 millilitre per 100 grams of body weight.) This dose level was split into two administrations, with one hour between doses
No. of animals per sex per dose:
5 male and 5 female dosed at 10 g/kg
5 male and 5 female dosed at 5 g/kg
Control animals:
no
Details on study design:
- Duration of observation period following administration: 1, 2 and 14 days (additional observations were made is suggested by Neurotoxicologist.)
- Frequency of observations and weighing: Weighing occurred at 7 and 14 days after dosing.
- Necropsy of survivors performed: Yes
Statistics:
None reported

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
approximate LD50
Effect level:
> 10 000 mg/kg bw
Based on:
test mat.
Mortality:
10 g/kg dose - 2/5 males and 2/5 females died
No lethality was observed at 5 mg/kg bw in either sex.
Clinical signs:
other: Several reported clinical signs were linked to excessive excretion of the compound including red extremities, unkempt appearance, discharge on perineal fur, greasy wet perineal fur and hindlimb regions, and alopecia and scabs on the perineal fur, hind lim
Gross pathology:
Necropsy revealed discoloration in lungs, intestines (with distention), liver (1 animal) and kidneys in rats that died or were sacrificed during the study period. Surviving animals had no remarkable gross lesions. No lesions were found in tissues taken to evaluate neurotoxicity (brains, spinal cords, sciatic nerves and pituitaries

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
No histopathological signs of lesions were found in the central or peripheral nervous system. Clinical signs were not considered to be related to the irritation of the abdominal and hindlimb areas. Based on these results, Gulftene 16 did not appear to produce primary neurotoxicant effect.
Executive summary:

In an acute oral toxicity study, two groups of 10 (male and female) Sprague-Dawley albino rats, 7 to 13 weeks of age, which had fasted for 18 hours, were given a single oral dose of hexadec-1 -ene at 10 g/kg or 5 g/kg. These animals were observed for a total of 14 days. There was no treatment related clinical signs, necropsy findings or changes in body weight. The oral LD50 was determined to be >10 g/kg bw in both males and females. This result can be considered representative of the likely acute oral toxicity of the isomer 7 -methylenepentadecane.